About Site
Help/FAQ
Contact Us
Editorial Board
Diabetes Roundtable - Diabetes Information for Physicians
Home
Recent Diabetes News
eGrand Rounds
CME Courses
Section Overview  
Initiating Insulin Therapy Earlier: Rationale, Strategies and Benefits  
Practical Aspects of Diabetes Care: Effective Use of Insulin Analogs:  
Practical Approaches to Reducing the Cost Burden Associated With Diabetes-Related Care:  
Insulin Therapy in the Primary Care Setting  
Diabetes Update 2003: Keys to Control  
Slide Library
Literature Update
Calendar of Events
Tools for Physicians
Patient Education Resources


CME CoursesCME CoursesCME CoursesCME Courses

Faculty

Back to CME Information
Michelle F. Magee, MD, CDE
Director, MedStar Diabetes Institute
at Washington Hospital Center
Washington, DC
Andrew Ahmann, MD
Associate Professor, Endocrinology, Diabetes and Clinical Nutrition
Department of Medicine
Endocrinology, Diabetes & Clinical Nutrition
Oregon Health & Science University
Portland, OR
Thomas W. Donner, MD
Associate Professor of Medicine
Medical Director, University of Maryland Joslin Diabetes Center
Director, Endocrinology, Diabetes, Metabolism Fellowship Training Program
Baltimore, MD
Mansur E. Shomali, MD
Associate Director, Division of Endocrinology
Associate Director, Diabetes and Endocrine Center
Director of Research, Department of Medicine
Union Memorial Hospital
Baltimore, MD

Conflict of Interest Disclosure

As a sponsor accredited by the ACCME, it is the policy of Washington Hospital Center to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity. The ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Faculty who refuse to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of a CME activity. For an individual with no relevant financial relationship(s), the participants must be informed that no relevant financial relationship(s) exist.

All faculty are also required to disclose any discussions of unlabeled/unapproved uses of drugs or devices.

  • Andrew Ahmann, MD: Speaker's Bureau: Novo Nordisk, Sanofi-Aventis

  • Thomas W. Donner, MD: Speaker's Bureau: Aventis

  • Michelle F Magee, MD, CDE: Consulting Fee: Aventis, Novo Nordisk; Contracted Research: Aventis, Novo Nordisk; Speaker's Bureau: Novo Nordisk, Aventis; Support for Education Programs: Aventis, Lilly

  • Mansur Shomali, MD: Speaker's Bureau: Novo Nordisk, Sanofi-Aventis

 

Entire site
Literature Articles
Go




Website sponsored by:
   
Terms of Use  Disclaimer  Privacy Policy  Site Map